U.S. Global Investors Stock Forecast, Price & News

U.S. Global Investors (NASDAQ:GROW) Frequently Asked Questions

How has U.S. Global Investors' stock price been impacted by Coronavirus?

U.S. Global Investors' stock was trading at $1.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, GROW shares have increased by 387.5% and is now trading at $5.07.
View which stocks have been most impacted by COVID-19.

When is U.S. Global Investors' next earnings date?

U.S. Global Investors is scheduled to release its next quarterly earnings announcement on Thursday, December 9th 2021.
View our earnings forecast for U.S. Global Investors.

How were U.S. Global Investors' earnings last quarter?

U.S. Global Investors, Inc. (NASDAQ:GROW) released its earnings results on Tuesday, February, 11th. The asset manager reported ($0.06) earnings per share for the quarter. The asset manager earned $0.89 million during the quarter. U.S. Global Investors had a trailing twelve-month return on equity of 113.41% and a net margin of 206.34%.
View U.S. Global Investors' earnings history.

How often does U.S. Global Investors pay dividends? What is the dividend yield for U.S. Global Investors?

U.S. Global Investors announced a monthly dividend on Tuesday, October 5th. Stockholders of record on Monday, December 13th will be given a dividend of $0.0075 per share on Monday, December 27th. This represents a $0.09 dividend on an annualized basis and a yield of 1.78%. The ex-dividend date is Friday, December 10th.
View U.S. Global Investors' dividend history.

Is U.S. Global Investors a good dividend stock?

U.S. Global Investors pays an annual dividend of $0.09 per share and currently has a dividend yield of 1.81%.
View U.S. Global Investors' dividend history.

Who are U.S. Global Investors' key executives?

U.S. Global Investors' management team includes the following people:

• Frank Edward Holmes, CEO, Director & Chief Investment Officer
• Lisa C. Callicotte, Chief Financial Officer
• Holly Schoenfeldt, Public Relations Leader

What is Frank E. Holmes' approval rating as U.S. Global Investors' CEO?

3 employees have rated U.S. Global Investors CEO Frank E. Holmes on Glassdoor.com. Frank E. Holmes has an approval rating of 51% among U.S. Global Investors' employees. This puts Frank E. Holmes in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of U.S. Global Investors' key competitors?

Some companies that are related to U.S. Global Investors include Monroe Capital (MRCC), Silvercrest Asset Management Group (SAMG), Hywin (HYW), StoneCastle Financial (BANX), Manning & Napier (MN), Westwood Holdings Group (WHG), Dundee (DDEJF), Great Elm Capital (GECC), Hennessy Advisors (HNNA), Puhui Wealth Investment Management (PHCF), BKF Capital Group (BKFG), Wright Investors' Service (IWSH), Winmill & Co. Incorporated (WNMLA), Fifth Street Asset Management (FSAM) and GlassBridge Enterprises (GLAE).
View all of GROW's competitors.

What other stocks do shareholders of U.S. Global Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Global Investors investors own include Intelsat (I), Bank of America (BAC), Fossil Group (FOSL), Gol Linhas Aéreas Inteligentes (GOL), Associated British Foods (ABF), Chaarat Gold (CGH), Ciena (CIEN), AMC Entertainment (AMC), First Data (FDC) and Apollo Global Management (APO).

What is U.S. Global Investors' stock symbol?

U.S. Global Investors trades on the NASDAQ under the ticker symbol "GROW."

Who are U.S. Global Investors' major shareholders?

U.S. Global Investors' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Heartland Advisors Inc. (2.99%), Clear Harbor Asset Management LLC (1.59%), Toroso Investments LLC (0.83%), Geode Capital Management LLC (0.73%), Renaissance Technologies LLC (0.71%) and Dimensional Fund Advisors LP (0.48%).
View institutional ownership trends for U.S. Global Investors.

Which institutional investors are selling U.S. Global Investors stock?

GROW stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Millennium Management LLC, Renaissance Technologies LLC, Heartland Advisors Inc., Citadel Advisors LLC, and Dimensional Fund Advisors LP.
View insider buying and selling activity for U.S. Global Investors or view top insider-selling stocks.

Which institutional investors are buying U.S. Global Investors stock?

GROW stock was acquired by a variety of institutional investors in the last quarter, including Clear Harbor Asset Management LLC, Formidable Asset Management LLC, LPL Financial LLC, Aristides Capital LLC, WINTON GROUP Ltd, Hodges Capital Management Inc., Toroso Investments LLC, and Advisor Group Holdings Inc..
View insider buying and selling activity for U.S. Global Investors or or view top insider-buying stocks.

How do I buy shares of U.S. Global Investors?

Shares of GROW can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Global Investors' stock price today?

One share of GROW stock can currently be purchased for approximately $5.07.

How much money does U.S. Global Investors make?

U.S. Global Investors has a market capitalization of $76.29 million and generates $4.48 million in revenue each year.

How many employees does U.S. Global Investors have?

U.S. Global Investors employs 22 workers across the globe.

What is U.S. Global Investors' official website?

The official website for U.S. Global Investors is www.usfunds.com.

Where are U.S. Global Investors' headquarters?

U.S. Global Investors is headquartered at 7900 CALLAGHAN RD, SAN ANTONIO TX, 78229.

How can I contact U.S. Global Investors?

U.S. Global Investors' mailing address is 7900 CALLAGHAN RD, SAN ANTONIO TX, 78229. The asset manager can be reached via phone at (210) 308-1234, via email at [email protected], or via fax at 210-308-1223.